Summary
- Current Price
- As of today, TVTX price is $44.80, down -0.24% on
- Current Price All-Time High
- TVTX price is currently -7.82% below its historical high of $48.60 set on
- Market Cap
- TVTX current market cap is $4B, up +117.65% over the past 365 days
- PE Ratio
- TVTX PE ratio is unknown
- Revenue
- TVTX current annual revenue is $490.73M, up +110.45% year-over-year
- Next Earnings
- As of today, the next earnings release for TVTX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Travere Therapeutics, Inc. |
| Ticker | NASDAQ: TVTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | travere.com |
| Employees | 385 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $44.80 | |
| Price, 1D Change | -0.24% | |
| $4B | ||
| - | ||
| - | ||
| 1.82 | ||
| $491M | ||
| Revenue, 1Y Change | +110.45% | |
| -$0.56 | ||
| EPS, 1Y Change | +86.18% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:9 | |
| Next Split | N/A | N/A |
| Last Ticker Change | RTRX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.56 | ||
| EPS Estimate | N/A | $1.60 |
| EPS Est. Change | N/A | +384.50% |
| $490.73M | ||
| Revenue Estimate | N/A | $697.46M |
| Revenue Est. Change | N/A | +42.13% |
| Current Price | $44.80 | |
| Price Target | - | $50.00 |
| Price Tgt. Change | - | +11.61% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.84 | -$4.08 | -43.71% | |
| $0.89 | -$0.56 | -163.00% | |
| $1.60 | N/A | +384.50% | |
| $4.87 | N/A | +964.91% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $231.13M | $233.18M | +0.88% | |
| $508.40M | $490.73M | -3.48% | |
| $697.46M | N/A | +42.13% | |
| $973.26M | N/A | +98.33% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $44.80 | |
| $29.06 | ||
| SMA 200 vs Price | -35.14% | |
| $32.87 | ||
| SMA 50 vs Price | -26.63% | |
| 1.82 | ||
| $2.37 | ||
| 72.22 | ||
| 37.05% | ||
| 75.09% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $490.73M | ||
| -$0.56 | ||
| $419.65M | ||
| 85.52% | ||
| -$62.82M | ||
| -12.80% | ||
| -$50.26M | ||
| -10.24% | ||
| -$2.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 2.86 | ||
| 2.74 | ||
| 2.70 | ||
| - | ||
| 6 | ||
| 2.68 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 8.43 | ||
| 36.04 | ||
| -1,994.28 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $114.83M | ||
| $322.80M | ||
| $605.19M | ||
| $437.57M | ||
| $490.36M | ||
| $159.90M | ||
| $328.73M | ||
| $5.88M | ||
| $24.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $540.99M | ||
| $482.47M | ||
| $71.08M | ||
| $337.20M | ||
| $60.74M | ||
| $0.00 | ||
| $988.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $37.78M | ||
| $27.89M | ||
| -$33.47M | ||
| $58.16M | ||
| -$20.37M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| JP Morgan | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with TVTX
FAQ
What is the ticker symbol for Travere Therapeutics, Inc.?
The ticker symbol for Travere Therapeutics, Inc. is NASDAQ:TVTX
Does Travere Therapeutics, Inc. pay dividends?
No, Travere Therapeutics, Inc. does not pay dividends
What sector is Travere Therapeutics, Inc. in?
Travere Therapeutics, Inc. is in the Healthcare sector
What industry is Travere Therapeutics, Inc. in?
Travere Therapeutics, Inc. is in the Biotechnology industry
What country is Travere Therapeutics, Inc. based in?
Travere Therapeutics, Inc. is headquartered in United States
When did Travere Therapeutics, Inc. go public?
Travere Therapeutics, Inc. initial public offering (IPO) was on November 8, 2012
Is Travere Therapeutics, Inc. in the S&P 500?
No, Travere Therapeutics, Inc. is not included in the S&P 500 index
Is Travere Therapeutics, Inc. in the NASDAQ 100?
No, Travere Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Travere Therapeutics, Inc. in the Dow Jones?
No, Travere Therapeutics, Inc. is not included in the Dow Jones index
When was Travere Therapeutics, Inc. last earnings report?
Travere Therapeutics, Inc.'s most recent earnings report was on May 4, 2026
When does Travere Therapeutics, Inc. report earnings?
The date for Travere Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- TVTX Official Website www.travere.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1438533/000143853326000014/0001438533-26-000014-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1438533/000143853326000014/0001438533-26-000014-index.htm
- TVTX Profile on Yahoo Finance finance.yahoo.com/quote/TVTX
- TVTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tvtx